{"cluster": 63, "subcluster": 5, "abstract_summ": "This paper is review of reported drug interactions of current treatments for COVID-19 and anticancer agents.\u2022 More safety data is needed to treat COVID-19 symptomatic patients with anticancer drugs known to increase infections.\u2022 We summarized immunosuppressing anticancer drugs; other drugs were studied for drug-drug interactions with antiviral medicines.Pharmacological expertise was required in various areas such as the daily healthcare of patients admitted to our hospitals [1], the implementation of pharmacokinetic and pharmacokinetic-pharmacodynamic studies in clinical trials of repurposed drugs [2] and even in providing up-to-date information to the general population [3].Patients with COVID-19 are sometimes already being treated for one or more other chronic conditions, especially if they are elderly.Here, we analyzed the potential or proven risk of the co-administration of drugs used for the most common chronic diseases and those currently offered as treatment or undergoing therapeutic trials for COVID-19.Because of the long-term use of chemotherapy drugs, drug interactions are important in these patients especially with SARS-CoV2 treatments now.", "title_summ": "Therapeutic Application of Chloroquine in Clinical Trials for COVID-19Considerations for interactions of drugs used for the treatment of COVID-19 with anti-Cancer treatmentsAnticancer drugs and COVID-19 antiviral treatments in cancer patients: what can we safely use?Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.", "title_abstract_phrases": "Pharmacological expertise was required in various areas such as the daily healthcare of patients admitted to our hospitals [1], the implementation of pharmacokinetic and pharmacokinetic-pharmacodynamic studies in clinical trials of repurposed drugs [2] and even in providing up-to-date information to the general population [3].Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.Anticancer drugs and COVID-19 antiviral treatments in cancer patients: what can we safely use?\u2022 More safety data is needed to treat COVID-19 symptomatic patients with anticancer drugs known to increase infections.Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.\u2022 We summarized immunosuppressing anticancer drugs; other drugs were studied for drug-drug interactions with antiviral medicines.This study meticulously evaluated the various dosages of chloroquine and hydroxychloroquine utilized in clinical trials registered in Chinese and US clinical trial registries for the treatment of pneumonia caused by SARS-CoV-2.Considerations for interactions of drugs used for the treatment of COVID-19 with anti-Cancer treatmentsSARS-CoV2 infection is an emerging issue worldwide."}